The Federal Trade Commission filed a lawsuit against the top three PBMs, alleging that they manipulated drug prices to inflate rebates, impacting patients. CVS, Cigna, and UnitedHealth Group stocks fell but the impact remains uncertain.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing